Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Darhult Medicinkonsult AB
AB
Active
Org 5594017658
Sven Rancksgatan 19
Hospital activities · NACE 8610
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 231K
-13% vs 2023
EBITDA margin
81.8%
-20% vs 2023
Equity ratio
56.0%
Financial strength
Net profit 2024
SEK 153K
-18% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 231K
-13%
EBITDA
SEK 189K
-20%
Net profit
SEK 153K
-18%
Total assets
SEK 318K
-1%
Equity
SEK 178K
-16%
Employees
0
—
Company information
Legal name
Darhult Medicinkonsult AB
Org number
5594017658
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
18 oktober 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolget skall erbjuda bemannings- och utbildningstjänster inom radiologi, handelmed värdepapper, samt därmed förenlig verksamhet.
Contact
Address
Sven Rancksgatan 19
Email
viktor.darhult@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Hospital activities
Companies in Halmstad
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
265
231
Staff expenses
—
—
EBITDA
235
189
Depreciation & amort.
−0
−0
EBIT
235
189
Net financials
—
4
Profit before tax
235
192
Tax
−49
−39
Net profit
186
153
Balance sheet
SEK thousands
Item
2023
2024
Total assets
322
318
Equity
211
178
Long-term debt
0
0
Short-term debt
112
140
Total debt
112
140
Financial ratios
5-year trend
EBITDA margin
81.8%
This company
15.8%
Market median
+418% vs market
2023
2024
Equity ratio
56.0%
This company
38.2%
Market median
+47% vs market
2023
2024
Return on equity
86.0%
This company
18.4%
Market median
+367% vs market
2023
2024
Net profit margin
66.2%
This company
8.1%
Market median
+717% vs market
2023
2024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
2023
2024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
VK
Viktor Karl Gustav Darhult
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SK
Sofie Kristina Gydell
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Darhult Medicinkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Viktor Karl Gustav Darhult
Chief Executive Officer
0 companies
Sofie Kristina Gydell
Deputy Board Member
0 companies